Overdue Revision Of EU Cancer Screening Would Benefit Medtech Industry As Incidence Skyrockets
Executive Summary
Council of the EU recommendations on cancer screening have not changed in some 20 years, yet the increase in cancer rates is alarming. Industry associations, COCIR and MedTech Europe have come out in support of the European Commission’s push for a revision.